https://www.taxtmi.com/news?id=35390 India commits to international collaboration on pandemic response, digital health and life sciences innovation, leveraging its role as a major supplier of affordable generics while shifting from volume to value through R&D and high value biopharma. Supportive measures cited include Production Linked Incentive schemes for pharma, bulk drugs and medical devices, genome initiatives, expanded public healthcare access, Jan Aushadhi centres and concessions for critical drugs; the government invites global investors to utilise India's talent, cost advantages and evolving innovation ecosystem. en-us Wed, 26 Feb 2025 21:31:04 +0530 Wed, 26 Feb 2025 21:31:04 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=35390 India commits to international collaboration on pandemic response, digital health and life sciences innovation, leveraging its role as a major supplier of affordable generics while shifting from volume to value through R&D and high value biopharma. Supportive measures cited include Production Linked Incentive schemes for pharma, bulk drugs and medical devices, genome initiatives, expanded public healthcare access, Jan Aushadhi centres and concessions for critical drugs; the government invites global investors to utilise India's talent, cost advantages and evolving innovation ecosystem. News - Wed, 26 Feb 2025 21:31:04 +0530 https://www.taxtmi.com/news?id=35390